Future Studies

Since the pandemic, Team Science has pioneered key studies on COVID-19, influenza and respiratory syncytial virus (RSV). We participated in the world's first convalescent plasma study for COVID-19 and in the investigation of the first mRNA vaccine against COVID. In addition, we investigated mRNA vaccines against influenza and RSV in older adults and pregnant women (approved in Argentina and incorporated in the National Vaccination Calendar for this population between 32 and 36 weeks of pregnancy).